Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July By: CNBC.com News March 06, 2023 at 09:19 AM EST Medicare has agreed to provide broader coverage once Leqembi receives full FDA approval. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July By: CNBC.com News March 06, 2023 at 09:19 AM EST Medicare has agreed to provide broader coverage once Leqembi receives full FDA approval. Read More >>